N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
US6908924B2 · kind B2 · utility
89Cited by
7References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2002 |
| Grant date | Jun 21, 2005 |
| Priority date | — |
| Expiry date | Dec 16, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a compound, method and composition of treating or preventing viral infections, in particular, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts, comprising the administration of N4-acylcytosine-1,3-dioxolane and pharmaceutically acceptable salts, prodrugs, and other derivatives thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.